President, Chief Science Officer and Director of Bus. Devel.Dr. Douglas P. Cerretti, Ph.D., is President of CellCyte Genetics Corporationrationration. He is a biopharmaceutical research scientist with experience in drug development in inflammation and cancer. From 1984 to 2002, he served with Immunex, and, after Immunex acquisition in 2002, with Amgen in positions ranging from Staff Scientist through Scientific Director. Dr. Cerretti retired from Amgen in 2007. He is the author or coauthor of more than 100 scientific publications and has over 40 issued US Patents to his name
Age: 61 President Since 2010 Ph.DCerretti has worked with Company since October 2009, initially as Chief Science Officer and Director of Business Development, where he helped formulate scientific and business strategies. He has also worked as a senior scientific consultant through DPC BioPharma Consulting of Seattle, Washington since 2008, formulating a business plan and scientific strategies for a potential stem cell product. From 2002 through 2007, Dr. Cerretti served as Scientific Director and Senior Research Scientist, Department of Cancer Biology for Amgen Corporationrationrationration. From 1984 through 2002, he served as a Senior Research Scientist for Immunex Corporationrationrationration within their departments of Vascular and Molecular Biology.